2nd Quarter - Report

MAYER BROWN LLP for TRANSMED FOODS, INC.

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Food Industry (safety, labeling, etc.) FOO

Interactions with House of Representatives and Senate offices and other government agencies regarding FDA Import Alert.

Foreign entity interest: Though the work was conducted on behalf of TransMed Foods, Inc. the client's parent, Societe Marocaine D'Industries Alimentaires (Somia) has an interest in the aforementioned issues.

LobbyistCovered position, as disclosed
TIMOTHY J KEELER New USTR, Chief of Staff, 2006-2009; US Treasury Department, Deputy to the Assistant Secretary of Legislative Affairs, 2001-2006; Presidential Transition Team, Policy Analyst, 2000-2001; Senate Finance Committee, Professional Staff, 1997-2000.
MICHAEL JOHNSON KELLEY —
ANTHONY J MOFFETT —
WARREN PAYNE New US Intl Trade Comm: Trade Analyst, 2002-04; Economic Advisor, 2004-07; House Ways + Means Committee: Trade Economist, 2007-09; Sr. Economist/Trade Advisor, 2009-11; Chief Economist, 2011-12, Policy Director, 2012-15.

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); State, Dept of (DOS)

Trade (domestic/foreign) TRD

Interactions with House of Representatives and Senate offices and other government agencies regarding FDA Import Alert.

Foreign entity interest: Though the work was conducted on behalf of TransMed Foods, Inc. the client's parent, Societe Marocaine D'Industries Alimentaires (Somia) has an interest in the aforementioned issues.

LobbyistCovered position, as disclosed
TIMOTHY J KEELER New USTR, Chief of Staff, 2006-2009; US Treasury Department, Deputy to the Assistant Secretary of Legislative Affairs, 2001-2006; Presidential Transition Team, Policy Analyst, 2000-2001; Senate Finance Committee, Professional Staff, 1997-2000.
MICHAEL JOHNSON KELLEY —
ANTHONY J MOFFETT —
WARREN PAYNE New US Intl Trade Comm: Trade Analyst, 2002-04; Economic Advisor, 2004-07; House Ways + Means Committee: Trade Economist, 2007-09; Sr. Economist/Trade Advisor, 2009-11; Chief Economist, 2011-12, Policy Director, 2012-15.

Contacted: State, Dept of (DOS); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.